ECHELON-3
ECHELON-3: Phase III, Placebo-Controlled Trial of Brentuximab Vedotin in Combination With Lenalidomide and Rituximab in R/R DLBCL

Released: June 06, 2024

Expiration: June 05, 2025

Activity

Progress
1
Course Completed